Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-009993

CHAIRMAN & CEO gave up 5,321 shares (to pay taxes)

  • CHAIRMAN & CEO acquired 12,719 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Sanj K CHAIRMAN & CEO 2025-04-01 Option exercise +6,481 90,597 D
Patel Sanj K CHAIRMAN & CEO 2025-04-01 Option exercise +6,238 96,835 D
Patel Sanj K CHAIRMAN & CEO 2025-04-01 Shares withheld for taxes −2,304 $21.77 $50,158 94,531 D
Patel Sanj K CHAIRMAN & CEO 2025-04-01 Shares withheld for taxes −3,017 $21.77 $65,680 91,514 D
Derivatives
Patel Sanj K CHAIRMAN & CEO 2025-04-01 Grant or award · Share Option +137,638 137,638 D
Patel Sanj K CHAIRMAN & CEO 2025-04-01 Grant or award · Restricted Share Unit +34,435 34,435 D
Patel Sanj K CHAIRMAN & CEO 2025-04-01 Grant or award · Performance Share Unit +68,869 68,869 D
Patel Sanj K CHAIRMAN & CEO 2025-04-01 Option exercise · Restricted Share Unit −6,481 12,962 D
Patel Sanj K CHAIRMAN & CEO 2025-04-01 Option exercise · Restricted Share Unit −6,238 18,712 D
Loading xslF345X05/form4-04032025_090418.xml…